Veklury® (Remdesivir) is First and Only Approved Treatment for Pediatric ... - Gilead Sciences

Retrieved on: 2022-04-25 18:40:06

Tags for this article:

Health sciences

COVID-19 drug development

COVID-19 drug repurposing research

Gilead Sciences Inc.

United States

FOSTER CITY

u.s. food and drug administration

Click the tags to see associated articles and topics

Veklury® (Remdesivir) is First and Only Approved Treatment for Pediatric ... - Gilead Sciences. View article details on HISWAI: https://www.gilead.com/news-and-press/press-room/press-releases/2022/4/veklury-remdesivir-is-first-and-only-approved-treatment-for-pediatric-patients-under-12-years-of-age-with-covid19

Excerpt

“This approval means that remdesivir can potentially provide meaningful clinical improvement, by reducing disease progression and helping children ...

Article found on: www.gilead.com

View Original Article